Ranolazine Tablet
Form: Tablet
Strength: 500 mg and 1000 mg
Reference Brands: Ranexa(US & EU)
Category: Heart Disorder
Ranolazine tablets, marketed as Ranexa, are approved in the US by the FDA and in the EU via EMA for the treatment of chronic angina. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe medication use, and global availability, helping millions manage angina and improve quality of life worldwide effectively.
Quick Response Guaranteed | Verified Suppliers
Back to ListingThe Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Aliskiren Tablets
Strength: 150 mg, 300 mg
Form: Tablets
Reference Brands: Tekturna(US & EU)
View Details
Atenolol Tablets
Strength: 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Tenormin(US)
View Details
Metoprolol Tartrate Tablet
Strength: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg
Form: Tablets(IR & ER)
Reference Brands: US: Lopressor(IR); Toprol-XL(ER)
View Details
Nifedipine Tablets(Ir/Er)
Strength: 10 mg, 20 mg, 30 mg, 60 mg, 90 mg (IR and ER forms)
Form: Tablet(IR & ER)
Reference Brands: Procardia(US);
View DetailsQuick Response Guaranteed | Verified Suppliers